TRex Bio Incorporation

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
Analyst consensus
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About TRex Bio Incorporation
Trex Bio Inc is a clinical-stage biopharmaceutical company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines designed to restore immune balance and promote tissue repair to address unmet needs of patients with autoimmune and inflammatory diseases.
Others were interested in
Frequently asked questions
To buy TRex Bio Incorporation stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for TRex Bio Incorporation by name or ticker, choose the number of shares, and place your order.
The ticker symbol for TRex Bio Incorporation is TRXB. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
TRex Bio Incorporation has its primary listing on NASDAQ. You can trade TRex Bio Incorporation with a Saxo account, alongside thousands of other stocks worldwide.
Yes, TRex Bio Incorporation is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include TRex Bio Incorporation as part of a broader investment portfolio.